Severity indices in rheumatoid arthritis: A systematic review
- PMID: 28807652
- DOI: 10.1016/j.reuma.2017.07.004
Severity indices in rheumatoid arthritis: A systematic review
Abstract
Objective: To identify tools designed to evaluate the severity of patients with rheumatoid arthritis (RA) in order to use them in the investigation of prognostic markers in early arthritis.
Methods: We conducted a systematic review of studies that developed/validated an index for RA disease severity. They were analyzed using the COSMIN checklist to assess their methodological quality. In addition, all the variables included were evaluated for their clarity of definition, feasibility and probability of being present in each outcome during the first 2 years of the disease course. To estimate redundancy, variables were grouped by domains.
Results: After reviewing 3,519 articles, 3 studies were included. The first study, the PAS, assessed whether current and lifetime treatment with disease-modifying antirheumatic drugs and/or biologics accurately predicted RA severity, as measured by the patient-reported PAS. Treatment variables did not fully distinguish patients in the highest and lowest quartiles of PAS scores. Another severity index, the Claims-Based Index for RA Severity (CIRAS), included the variables age, sex, Felty's syndrome, number of rehabilitation and rheumatology visits, test for inflammatory markers, number of chemistry panels/platelet counts ordered and rheumatoid factor test. The correlation was low (r=0.56) with an index previously validated by the same research group, the RA medical records-based index of severity (RARBIS), with Disease Activity Score-C-reactive protein (DAS28-PCR) (r=0.07) and Multidimensional Health Assessment Questionnaire (MD-HAQ) (r=0.008). Finally, the RARBIS, used to validate the CIRAS, was devised as an RA severity index based on medical records. It includes as domains surgery, radiology, extra-articular manifestations, clinical and laboratory variables, previously chosen by an expert panel. RARBIS had a weak correlation with treatment intensity (r=0.35) and with DAS28 (r=0.41).
Conclusion: There is no index to assess the severity of RA based on the course of the first 2 years of follow-up that is adapted to the current strategy of therapeutic management of this disease. Therefore, we believe it is reasonable to develop a new ad hoc severity index for patients with early arthritis.
Keywords: Artritis de inicio; Artritis reumatoide; Early arthritis; Gravedad; Index or questionnaire; Revisión sistemática; Rheumatoid arthritis; Severity; Systematic review; Índices o cuestionarios.
Copyright © 2017 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.
Similar articles
-
Development of a health care utilisation data-based index for rheumatoid arthritis severity: a preliminary study.Arthritis Res Ther. 2008;10(4):R95. doi: 10.1186/ar2482. Epub 2008 Aug 21. Arthritis Res Ther. 2008. PMID: 18717997 Free PMC article.
-
Rheumatoid arthritis disease severity indices in administrative databases: a systematic review.J Rheumatol. 2011 Nov;38(11):2318-25. doi: 10.3899/jrheum.110587. Epub 2011 Sep 15. J Rheumatol. 2011. PMID: 21921094
-
The validity of a rheumatoid arthritis medical records-based index of severity compared with the DAS28.Arthritis Res Ther. 2006;8(3):R57. doi: 10.1186/ar1921. Epub 2006 Mar 14. Arthritis Res Ther. 2006. PMID: 16542499 Free PMC article.
-
Performance of a rheumatoid arthritis records-based index of severity.J Rheumatol. 2005 Sep;32(9):1679-87. J Rheumatol. 2005. PMID: 16142860
-
Assessing prognosis and prediction of treatment response in early rheumatoid arthritis: systematic reviews.Health Technol Assess. 2018 Nov;22(66):1-294. doi: 10.3310/hta22660. Health Technol Assess. 2018. PMID: 30501821 Free PMC article.
Cited by
-
Editorial: Multidisciplinary approach to interstitial lung disease associated with systemic rheumatic diseases.Front Med (Lausanne). 2022 Dec 13;9:1112872. doi: 10.3389/fmed.2022.1112872. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36582281 Free PMC article. No abstract available.
-
A clinical practice guideline for the management of the foot and ankle in rheumatoid arthritis.Rheumatol Int. 2024 Aug;44(8):1381-1393. doi: 10.1007/s00296-024-05633-1. Epub 2024 Jun 8. Rheumatol Int. 2024. PMID: 38850327 Free PMC article. Review.
-
Therapeutic Advances in Psoriasis: From Biologics to Emerging Oral Small Molecules.Antibodies (Basel). 2024 Sep 14;13(3):76. doi: 10.3390/antib13030076. Antibodies (Basel). 2024. PMID: 39311381 Free PMC article. Review.
-
Pathogenesis and Current Treatment Strategies in Rheumatoid Arthritis: A Systematic Review Article.Ann Afr Med. 2025 Jul 1;24(3):532-539. doi: 10.4103/aam.aam_11_24. Epub 2025 May 2. Ann Afr Med. 2025. PMID: 40317112 Free PMC article.
-
The impact of rehabilitation frequency on the risk of stroke in patients with rheumatoid arthritis.PLoS One. 2020 Jan 13;15(1):e0227514. doi: 10.1371/journal.pone.0227514. eCollection 2020. PLoS One. 2020. PMID: 31929568 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials